| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 46.6145 | 35 |
| GSM780708 | Untreated after 4 days (C2_1) | 44.7878 | 26 |
| GSM780709 | Untreated after 4 days (C3_1) | 46.2044 | 33 |
| GSM780719 | Untreated after 4 days (C1_2) | 50.2105 | 49 |
| GSM780720 | Untreated after 4 days (C2_2) | 47.5632 | 39 |
| GSM780721 | Untreated after 4 days (C3_2) | 46.4121 | 34 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 43.4337 | 19 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 49.9948 | 48 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 45.8828 | 31 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 49.1238 | 45 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 44.8807 | 26 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 47.0475 | 37 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 62.4253 | 66 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 53.6979 | 57 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 64.0368 | 67 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 74.8257 | 70 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 47.6882 | 40 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 55.8156 | 61 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 46.8971 | 36 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 46.3533 | 34 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 43.9891 | 22 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 55.0295 | 60 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 40.8102 | 9 |